Evidence map›Paper›PMID 40050785›Full record

Observational studyBMC neurology2025

Dynamic changes in neuron-specific enolase level to glasgow coma scale score ratio predict long-term neurological function of diffuse axonal injury patients.

Weiliang Chen, Jiayi Wu, Shengwen Li, Chunyu Yao, Rui Chen, Wen Su, Guanjun Wang

Abstract readObservational Study
In one paragraph

Observational study in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Weiliang ChenDepartment of Neurosurgery, Haining People's Hospital, Haining, Zhejiang, China.
Jiayi WuDepartment of Clinical Laboratory, Haining People's Hospital, Haining, Zhejiang, China.
Shengwen LiDepartment of Orthopaedics, Haining People's Hospital, Haining, Zhejiang, China.
Chunyu YaoDepartment of Neurosurgery, Haining People's Hospital, Haining, Zhejiang, China.
Rui ChenDepartment of Neurosurgery, Haining People's Hospital, Haining, Zhejiang, China.
Wen SuDepartment of Neurosurgery, Haining People's Hospital, Haining, Zhejiang, China.
Guanjun WangDepartment of Neurosurgery, Haining People's Hospital, Haining, Zhejiang, China. hainingwwwhk@163.com.

Funding

Haining Science and Technology Plan Project 2021058
6 · The paper itself

Abstract

backgroundPatients with diffuse axonal injury (DAI) are often plagued by sequelae, and the current indicators for predicting long-term neurological function are not accurate enough. Our previous studies have found that serum Neuron-specific enolase (NSE) level to Glasgow Coma Scale (GCS) score ratio(NGR) at admission could be used as an independent predictor of DAI.

objectiveTo explore the accuracy of dynamic changes of NGR in predicting long-term neurological function in patients with DAI.

methodsPatients with DAI were included based on clinical MRI as the diagnostic standard, and divided into two groups with favorable and unfavorable outcome according to the 6-month Extended Glasgow Outcome Scale (GOSE) as the prognosis indicator. The differences in clinical parameters between the two groups of patients were compared by Pearson correlation analysis. The trend of dynamic changes in NSE, GCS, and NGR at 1st, 3rd, 5th, 7th and 14th days after injury were shown by line graphs. The predictive efficacy of various parameters for long-term neurological function were further analyzed by receiver operator characteristic (ROC) curves.

resultsAmong the 102 DAI patients, 75 (73.5%) were classified to favorable outcome group (GOSE5-8) and 27 (26.5%) to unfavorable outcome (GOSE1-4). The NSE, NGR and Marshall CT grade at the first day after injury in the favorable outcome group were significantly lower than those in the unfavorable outcome group (p = 0.005, p < 0.001, p = 0.002), but the GCS score was significantly higher than that of the latter (p = 0.006). There was a negative correlation between NGR at 1st, 3rd, 5th, 7th, and 14th days post-TBI (r1=-0.557, r3=-0.746, r5=-0.761, r7=-0.727, r14=-0.694), and the 6-month GOSE. DAI patients with a favorable outcome exhibited a gradual decline in NGR. The area under the ROC curves (AUC) of NGR at 1st, 3rd and 5th days post-TBI were 0.751 (95% CI, 0.646-0.856, p < 0.001), 0.913 (95% CI, 0.859-0.967, p < 0.001), 0.934 (95% CI, 0.886-0.982, p < 0.001), which were the largest among the three parameters.

conclusionsThe dynamic changes of NGR may be an accurate predictor of long-term neurological function in patients with DAI. CLINICAL

trial registrationTrial Registration Number ChiCTR2100044352, registration date was March 17, 2021.

Indexed as

Diffuse Axonal InjuryGlasgow Coma ScalePhosphopyruvate HydrataseAdolescentAdultAgedBiomarkersFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedPredictive Value of TestsPrognosisRetrospective StudiesROC CurveBiomarkersPhosphopyruvate HydrataseDiffuse axonal injuryDynamic changeGlasgow coma scaleNeurological functionNeuron specific enolase

Identifiers

PMID40050785
PMCPMC11884207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.